✦ LIBER ✦

Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review

✍ Scribed by Thomas E. Delea; John Edelsberg; Oleg Sofrygin; Simu K. Thomas; Jean-Francois Baladi; Pradyumna D. Phatak; Thomas D. Coates

Book ID: 109143799
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 166 KB
Volume: 47
Category: Article
ISSN: 0372-1248
DOI: 10.1111/j.1537-2995.2007.01416.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Iron chelation therapy associated with i

Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients

✍ Esther Natalie Oliva; Francesca Ronco; Antonio Marino; Caterina Alati; Giulia Pr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Use of deferiprone for iron chelation in

Use of deferiprone for iron chelation in patients with transfusion-dependent thalassaemia

✍ Saumya Shekhar Jamuar; Angeline Hwei Meeng Lai; Ah Moy Tan; Mei Yoke Chan; Ee Sh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Improved survival in red blood cell tran

Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy

✍ Heather A. Leitch; Jocelyn M. Chase; Trisha A. Goodman; Hatoon Ezzat; Meaghan D. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

## Abstract Many patients with primary myelofibrosis (PMF) become red blood cell (RBC) transfusion dependent (TD), risking iron overload (IOL). Iron chelation therapy (ICT) may decrease the risk of haemosiderosis associated organ dysfunction, though its benefit in PMF is undefined. To assess the ef

Effect of iron chelator deferasirox on c

Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome

✍ Takamasa Nishiuchi; Yuichi Okutani; Toshikazu Fujita; Kazuya Yoshida; Hiroaki Oh 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 216 KB

Iron chelation therapy: Clinical effecti

Iron chelation therapy: Clinical effectiveness, economic burden and quality of life in patients with iron overload

✍ Krista A. Payne; Diana Rofail; Jean-François Baladi; Muriel Viala; Linda Abetz; 📂 Article 📅 2008 🏛 Springer Healthcare Communications 🌐 English ⚖ 429 KB

Tophaceous gout in a patient with sickle

Tophaceous gout in a patient with sickle cell-thalassemia: case report and review of the literature

✍ Robert D. Leff; Marlene A. Aldo-Benson; Rose Spitz Fife 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 3 views

Secondary gout is a recognized complication of several hematologic disorders, including many chronic hemolytic anemias characterized by increased purine metabolism. However, gouty arthritis has been described in only a few patients with hemoglobinopathies, and the identification of typical monosodiu